
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
claudin-4 CRISPR/Cas9 KO Plasmid (h2) | sc-401284-KO-2 | 20 µg | $397.00 | |||
claudin-4 HDR Plasmid (h2) | sc-401284-HDR-2 | 20 µg | $445.00 |
CLDN4 encodes claudin-4, a tetraspan tight junction protein that regulates paracellular barrier permeability and apical–basal polarity in epithelial tissues. By organizing tight junction strands and coordinating with scaffold proteins such as ZO-1, claudin-4 influences junctional assembly, cell–cell adhesion, and epithelial differentiation programs that intersect with signaling networks controlling proliferation and migration. Dysregulated CLDN4 expression or localization is linked to epithelial barrier defects and altered tissue architecture, and is frequently studied in the context of tumor biology, including changes associated with epithelial–mesenchymal plasticity and metastatic potential. As a surface-exposed junctional component, claudin-4 also serves as a practical marker for epithelial lineage and junction integrity in mechanistic cell biology studies.
claudin-4 CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the CLDN4 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the CLDN4 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, claudin-4 HDR Plasmid (h2) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined CLDN4 target site.
When co-transfected with claudin-4 CRISPR/Cas9 KO Plasmid (h2):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the CLDN4 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.